4//SEC Filing
Palmetto Partners, Ltd. 4
Accession 0000908662-18-000170
CIK 0001346302other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 7:16 PM ET
Size
19.9 KB
Accession
0000908662-18-000170
Insider Transaction Report
Form 4
Palmetto Partners, Ltd.
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+930,383→ 930,383 total - Conversion
Common Stock
2018-06-25+581,992→ 1,512,375 total - Conversion
Common Stock
2018-06-25+447,686→ 1,960,061 total - Purchase
Common Stock
2018-06-25$15.00/sh+150,000$2,250,000→ 2,110,061 total - Conversion
Series B Preferred Stock
2018-06-25−797,384→ 0 total→ Common Stock (447,686 underlying) - Conversion
Series A Preferred Stock
2018-06-25−1,657,125→ 0 total→ Common Stock (930,383 underlying) - Conversion
Series B Preferred Stock
2018-06-25−1,036,599→ 0 total→ Common Stock (581,992 underlying)
Palmetto Partners 2014, LP
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2018-06-25−1,657,125→ 0 total→ Common Stock (930,383 underlying) - Conversion
Common Stock
2018-06-25+930,383→ 930,383 total - Conversion
Common Stock
2018-06-25+447,686→ 1,960,061 total - Purchase
Common Stock
2018-06-25$15.00/sh+150,000$2,250,000→ 2,110,061 total - Conversion
Series B Preferred Stock
2018-06-25−1,036,599→ 0 total→ Common Stock (581,992 underlying) - Conversion
Common Stock
2018-06-25+581,992→ 1,512,375 total - Conversion
Series B Preferred Stock
2018-06-25−797,384→ 0 total→ Common Stock (447,686 underlying)
Palmetto Partners 2015, LP
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+447,686→ 1,960,061 total - Conversion
Common Stock
2018-06-25+930,383→ 930,383 total - Conversion
Common Stock
2018-06-25+581,992→ 1,512,375 total - Conversion
Series B Preferred Stock
2018-06-25−1,036,599→ 0 total→ Common Stock (581,992 underlying) - Conversion
Series B Preferred Stock
2018-06-25−797,384→ 0 total→ Common Stock (447,686 underlying) - Purchase
Common Stock
2018-06-25$15.00/sh+150,000$2,250,000→ 2,110,061 total - Conversion
Series A Preferred Stock
2018-06-25−1,657,125→ 0 total→ Common Stock (930,383 underlying)
Footnotes (4)
- [F1]The securities are owned by Palmetto Partners, 2014, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2015, LP.
- [F2]Each share of Preferred Stock automatically converted into Common Stock, for no additional payment or consideration, on a 1.78112-for-1 basis, at the closing of the Issuer's initial public offering on June 25, 2018 and had no expiration date.
- [F3]The securities are owned by Palmetto Partners 2015, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2014, LP.
- [F4]The securities are owned by Palmetto Partners, Ltd., who is a member of a group with Palmetto Partners 2014, LP and Palmetto Partners 2015, LP.
Documents
Issuer
XERIS PHARMACEUTICALS INC
CIK 0001346302
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001744226
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 7:16 PM ET
- Size
- 19.9 KB